Antitope Announces Research Agreement with ChemomAb for Generation of Composite Human Antibodies against Inflammatory Diseases

Mercia EIS Funds | 31st July, 2013
Antitope Announces Research Agreement with ChemomAb for Generation of Composite Human Antibodies against Inflammatory Diseases
Mercia EIS Funds | 29th July, 2013
Mercia Fund Management makes investment to help accelerate the growth of PolyTherics
Mercia EIS Funds | 24th July, 2013
Oxford Genetics secures funding for DNA cloning system
Mercia EIS Funds | 26th June, 2013
How Mercia Fund Management funds University of Keele spin-outs
Mercia EIS Funds | 24th June, 2013
PsiOxus Therapeutics initiates second clinical study of oncolytic vaccine
Mercia EIS Funds | 18th June, 2013
Ventive named national runner up in Shell Springboard awards 2013
Mercia EIS Funds | 23rd May, 2013
Irresistible Materials secures funding boost and new Chairman
Mercia EIS Funds | 9th May, 2013
Shell Springboard regional winner Ventive secures £900,000 funding
Mercia EIS Funds | 8th May, 2013
Dr Christine Wilkinson Blanc joins Psioxus Therapeutics as Chief Medical Officer
Mercia EIS Funds | 15th April, 2013
Mercia Fund Management announces Carlton Jones as nanoTherics’ CEO